Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ACXP
ACXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACXP News
Acurx Pharmaceuticals Q4 2025 Earnings Call Highlights
Mar 13 2026
seekingalpha
Acurx Pharmaceuticals Reports Q4 Loss, Shares Drop
Mar 13 2026
Benzinga
Acurx Pharmaceuticals Reports 2025 Financial Highlights
Mar 13 2026
PRnewswire
Acurx Pharmaceuticals Reports 2025 Financial Results and Clinical Advances
Mar 13 2026
Newsfilter
Acurx Pharmaceuticals Reports Q4 Earnings
Mar 13 2026
seekingalpha
Acurx Pharmaceuticals Shares Pull Back After 107.93% Rally
Mar 12 2026
Benzinga
Petco Reports Strong Q4 Results, Shares Surge
Mar 12 2026
Benzinga
Acurx Pharmaceuticals Stock Surges Amid Positive Developments
Mar 11 2026
Benzinga
ACURX PHARMACEUTICALS ANNOUNCES SALARY REDUCTIONS FOR CEO, EXECUTIVE CHAIRMAN, AND CFO EFFECTIVE APRIL 1, 2026, ACCORDING TO SEC FILING
Mar 09 2026
moomoo
Acurx Advances CDI Patient Program to Phase 3 Trials
Mar 09 2026
PRnewswire
Acurx Launches New Clinical Trial for Recurrent CDI Treatment
Mar 09 2026
Yahoo Finance
Acurx Pharmaceuticals to Release 2025 Financial Results
Feb 16 2026
PRnewswire
Acurx Pharmaceuticals to Discuss 2025 Financial Results on March 13, 2026
Feb 16 2026
Newsfilter
"New to The Street Celebrates Milestone Episode #700 Airing Today at 6:30 PM ET on Bloomberg Television"
Nov 15 2025
Yahoo Finance
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
Nov 12 2025
PRnewswire
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
Nov 10 2025
PRnewswire
Show More News
